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Abstract
Since the discovery of HIV-1 circulating recombinant form (CRF) 33_01B in Malaysia in the early 2000 s, continuous genetic
diversification and active recombination involving CRF33_01B and other circulating genotypes in the region including
CRF01_AE and subtype B9 of Thai origin, have led to the emergence of novel CRFs and unique recombinant forms. The
history and magnitude of CRF33_01B transmission among various risk groups including people who inject drugs (PWID)
however have not been investigated despite the high epidemiological impact of CRF33_01B in the region. We update the
most recent molecular epidemiology of HIV-1 among PWIDs recruited in Malaysia between 2010 and 2011 by population
sequencing and phylogenetic analysis of 128 gag-pol sequences. HIV-1 CRF33_01B was circulating among 71% of PWIDs
whilst a lower prevalence of other previously dominant HIV-1 genotypes [subtype B9 (11%) and CRF01_AE (5%)] and
CRF01_AE/B9 unique recombinants (13%) were detected, indicating a significant shift in genotype replacement in this
population. Three clusters of CRF01_AE/B9 recombinants displaying divergent yet phylogenetically-related mosaic genomes
to CRF33_01B were identified and characterized, suggestive of an abrupt emergence of multiple novel CRF clades. Using
rigorous maximum likelihood approach and the Bayesian Markov chain Monte Carlo (MCMC) sampling of CRF33_01Bpol
sequences to elucidate the past population dynamics, we found that the founder lineages of CRF33_01B were likely to have
first emerged among PWIDs in the early 1990 s before spreading exponentially to various high and low-risk populations
(including children who acquired infections from their mothers) and later on became endemic around the early 2000 s.
Taken together, our findings provide notable genetic evidence indicating the widespread expansion of CRF33_01B among
PWIDs and into the general population. The emergence of numerous previously unknown recombinant clades highlights
the escalating genetic complexity of HIV-1 in the Southeast Asian region.
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Introduction
By the end of 2011, the Joint United Nations Program on HIV/
AIDS (UNAIDS) estimated around 4 million people were living
with HIV in Southeast Asia, indicating an 8% increase compared
to that in a decade ago. Furthermore, 280,000 new HIV infections
had occurred within the same year [1], highlighting the increasing
burden of HIV/AIDS faced by many countries in the region. Use
of unsterile injecting equipment represents one of the most
prevalent mode of HIV transmission as depicted in a 2008 study
which estimated a total of 16 million people who injected drugs, of
whom 3 million people were infected with HIV [2]. Transmission
of HIV among people who inject drugs (PWID) continues to
prevail in Southeast Asia, Eastern Europe and Latin America – at
present, five countries are thought to be facing mega-epidemics
from injecting drug use, namely China, Vietnam, Russia, Ukraine
and Malaysia (where the term mega-epidemic refers to a country
which has more than 75,000 registered cases of HIV infections in a
particular risk group) [3]. In particular, Southeast and East Asia
are home to around 4 million PWIDs in 2010 and displayed a
HIV prevalence rate of almost 20% [4]. In Malaysia, a total of
94,841 cases of HIV infections have been reported by the end of
2011 since the country’s first confirmed case in 1986. The HIV
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epidemic is largely concentrated amongst PWIDs contributing to
70–80% of the overall HIV prevalence in the country [5].
In Southeast Asia, Thailand has been the epicenter of the HIV/
AIDS epidemic for many decades. In this country, the early HIV
epidemic was initiated by two HIV-1 genotypes, circulating
recombinant form (CRF) 01_AE (CRF01_AE) and subtype B
(including subtype B9, the Thai variant of subtype B), albeit
circulating independently among different risk groups. HIV-1
CRF01_AE, believed to be of central African origin, initially
propagated among commercial sex workers and their clients while
subtype B9 circulated among PWIDs [6]. However, nearly a
decade later in the mid-1990 s, CRF01_AE was reported to have
infiltrated the PWIDs population, circulating in approximately
80% of PWIDs in Thailand [7]. As a result of the high CRF01_AE
prevalence and the fact that drug trafficking activities were
common across the region [8], CRF01_AE was later found to be
disseminating widely among PWIDs in other parts of Southeast
Asia and East Asia, including Cambodia, Vietnam, Malaysia,
China, Taiwan, Korea and Japan [9–11]. To date, CRF01_AE is
still circulating widely in Southeast Asia and causes the majority of
HIV infections in the region [6,12]. In Malaysia, the early HIV
epidemic in the 1990 s implied a similar trend to that of
Thailand’s initial HIV epidemic – CRF01_AE and subtype B9
were predominant among those with high-risk heterosexual
exposures and injecting drug practices, respectively [13–15]. In
the early 2000 s, Tee et al. reported that whilst subtype B9
remained the predominant subtype amongst PWIDs, the high
genetic plasticity and co-circulation of distinct HIV-1 genotypes
had contributed to the emergence of unique CRF01_AE/B9 inter-
subtype recombinants in the population of PWIDs [16,17], similar
to other studies by Tovanabutra et al. reporting the upsurge of
CRF01_AE/B9 recombinants in more than half of a high-risk
cohort in Thailand [18].
Interestingly, co-circulation of and dual infection involving
CRF01_AE and subtype B9 in Southeast Asia paved the way to the
emergence of six novel and genetically distinct CRF01_AE/B9
recombinants of epidemiological significance in the region:
CRF15_01B [19] and CRF34_01B [20] in Thailand, CRF33_01B
[21] and CRF48_01B [22] in Malaysia, CRF51_01B [23] in
Singapore, and CRF52_01B [24] both in Thailand and Malaysia.
The emergence and distribution of these new CRFs is however not
limited to the country of origin. For instance, CRF33_01B was
disseminating widely in various high-risk populations in Malaysia,
primarily in PWIDs [21]. In recent years, CRF33_01B has been
steadily expanding across the borders to Singapore [25,26],
Indonesia [27,28] and also Hong Kong [29]. In addition to the
spread of CRF33_01B into neighbouring countries, continuous
diversification through active recombination between CRF33_01B
and other CRF01_AE and/or subtype B9 strains have resulted in
the upsurge of new CRF and unique recombinant forms (URF)
that show divergent yet phylogenetically-related mosaic genomes
with CRF33_01B [22,27,30]. Therefore, co-circulation of viral
lineages, continual gene flow between and among the concentrat-
ed and generalized host populations and frequent genetic
recombination – involving various established CRF01_AE and
subtype B9 clades, the recently discovered CRFs, and unique
CRF01_AE/B9 recombinants – would most likely lead to the
escalation of HIV-1 genetic complexity in the region. Although
unsafe injection of unsterile equipment remain the major mode of
HIV transmission in Malaysia and also elsewhere in the region,
recent data on the genetic dispersion of various HIV-1 genotypes
among PWIDs, including the history of transmission and
dominance of distinct CRFs, is unavailable. Therefore, in this
study, we aim to investigate the rapidly evolving molecular
epidemiological profiles of HIV-1 among PWIDs in Kuala
Lumpur, Malaysia through the incorporation of rigorous phylo-
genetic analyses and a high-resolution Bayesian resampling
approach.
Materials and Methods
Ethics Statement
The study was approved by the University Malaya Medical
Centre (UMMC) Medical Ethics Committee. Standard, multilin-
gual consent forms allowed by the Medical Ethics Committee were
used. Written consent was obtained from all study participants.
Study Subjects and Specimens
A total of 158 consented PWIDs were recruited among inmates
of a prison (n= 118) and attendees of a needle syringe exchange
program (n= 40) in Kuala Lumpur, Malaysia between the period
of July and November 2010 and April and May 2011, respectively.
All recruited subjects reported a history of unsafe injecting drug
use in the questionnaires provided. Plasma samples were collected
from all 158 subjects, serologically determined to be HIV-1
positive and stored at 280uC until processed. No HIV-2 infections
were detected.
Viral RNA Isolation, Amplification and Sequencing
HIV-1 Viral RNA was extracted from plasma by column
purification method (QIAamp Viral RNA Mini Kit, Qiagen,
Hilden, Germany) and reverse transcribed into cDNA using
SuperScript III RNase H2 Reverse Transcriptase (Invitrogen,
Carlsbad, California, USA) and random hexamers (Applied
Biosystems, USA) according to the manufacturer’s instructions.
Nested PCR was performed separately to amplify the gag-pol gene
that spans the gag (p24), protease (PR) and reverse transcriptase
(RT) genes using QIAGEN HotStarTaq Plus DNA polymerase
(Qiagen, Hilden, Germany). The thermal conditions used in the
first and second round of PCR were initial denaturation at 95uC
for 5 minutes, followed by denaturation at 94uC for 30 seconds,
annealing at 50uC for 30 seconds, elongation at 72uC for 1 minute
and 30 seconds and a final elongation step at 72uC for 10 minutes.
The primers [31] used to amplify the gag-PR genes in the first
round of PCR were 507A (59-AAG GAA CCC TTT AGA GAC
TAT GTA GA-39; nucleotide positions relative to HXB2:1657–
1682) and 503B (59-TAT GGA TTT TCA GGC CCA ATT TTT
G-39; HXB2:2692–2716), followed by primers 508A (59-GTA
AAA AAT TGG ATG ACA GAA ACC TTG-39; HXB2:1726–
1752) and 504B (59-ACT TTT GGG CCA TCC ATT CC-39;
HXB2:2611–2592) in the second round of PCR. Meanwhile for
RT gene amplification, primers 325A (59-GGA AAC CAA AAA
TGA TAG GGG GAA TTG GAG G-39; HXB2:2377–2407) and
326B (59-CTG TAC TTC TGC TAC TAA GTC TTT TGA
TGG G-39; HXB2:3539–3509) were used in the first round of
PCR while primers 327A (59-GTG GAA AAA AGG CTA TAG
GTA CAG-39; HXB2:2452–2475) and 328B (59-CTG CCA ACT
CTA ATT CTG CTT C-39; HXB2:3462–3441) were used in the
second round of PCR. The PCR products were purified and
population sequencing was performed in an ABI PRISM 3730XL
DNA Analyzer using BigDye terminators (Applied Biosystems,
Foster City, California, USA).
Phylogenetic and Recombination Analysis
The gag-pol nucleotide sequences were assembled using DNASis
Max (Hitachi, Japan) to form a 1683 bp contig (HXB2:1753–
3440) for samples in which both gag-PR and RT genes were
successfully amplified. The gag-pol contigs were aligned with the
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HIV-1 reference subtypes and CRFs downloaded from the Los
Alamos HIV database (http://www.hiv.lanl.gov/) using ClustalX
2.0. The nucleotide sequences were then manually adjusted using
BioEdit 7.0 with reference to the HIV Sequence Compendium
2011 (http://www.hiv.lanl.gov/) to ensure accurate codon align-
ment. Phylogenetic trees were constructed by the neighbour-
joining method [32] based on the Kimura two-parameter model
with a transition-transversion ratio of 2.0 [33] implemented in
MEGA 5.05 [34]. The reliability of the branching orders were
analysed by bootstrap analysis of 1000 replicates. For samples in
which either gag-PR or RT was successfully amplified, the
nucleotide sequences were manually aligned and used to construct
phylogenetic trees for the gag-PR (HXB2:1753–2591, 834 bp) or
RT genes (HXB2:2476–3440, 966 bp) respectively in order to
determine the evolutionary relationship. Nucleotide sequences
obtained in the study were screened for novel HIV-1 recombinant
structures using the Recombinant Identification Program (RIP)
available at the Los Alamos HIV database. Following RIP
estimation, bootscanning and informative-site analyses [35] were
performed on recombinant genotypes using SimPlot version 3.5.1
[36]. In order to confirm the putative parental origin of each
recombinant segment, sub-region neighbour-joining tree analyses
were constructed in MEGA 5.05. In this study, we defined a
‘‘cluster" in the context of recombination as a clade consisting of at
least three sequences [37–39] displaying identical recombination
structures and breakpoints in the gag-pol genes. All sequences
reported in this study have been deposited in GenBank with
accession numbers KC477938 to KC478065.
Estimating the Past Population Dynamics of CRF33_01B
In order to infer the evolutionary history and population
dynamics of HIV-1 CRF33_01B in Kuala Lumpur and also other
regions in Malaysia, all previously reported genetic sequences
isolated from various risk populations were retrieved from the Los
Alamos HIV database and our in-house laboratory database,
including the gag-pol gene sequences newly amplified from all
CRF33_01B isolates reported in this study. As a result, a total of
242 CRF33_01B sequence data set with recorded sampling year
spanning 2005–2012 (inclusive of 152 and 90 sequences with
known and unknown transmission risks, respectively) sampled
from the central, northern and eastern states in Malaysia were
analysed. All CRF33_01B sequences were aligned and maximum
likelihood analysis of the 152 sequences with known transmission
Figure 1. Phylogenetic analysis of the 1.6 kb HIV-1 gag-pol
sequences (HXB2:1753–3440) amplified among people who
inject drugs (PWID) in Kuala Lumpur, Malaysia. The gag-pol
genes (n = 98) were sequenced, codon-aligned and manually adjusted
with the HIV-1 reference subtypes and circulating recombinant forms
(CRFs) retrieved from the Los Alamos HIV database (http://www.hiv.lanl.
gov/). Neighbour-joining tree was constructed in MEGA 5.05 [34] using
Kimura 2-parameter method of nucleotide substitutions to estimate
pair-wise evolutionary distance and the reliability of the branching
nodes were assessed by bootstrap analysis of 1000 replicates. Reference
strains of established and informative HIV-1 genotypes – CRF01_AE,
subtype B (including Thai B9), CRF15_01B, CRF34_01B CRF33_01B,
CRF48_01B, CRF51_01B, CRF52_01B and other relevant unique recom-
binant forms (URFs) circulating in Southeast Asia were also included in
the analysis to improve tree resolution. Other HIV-1 genotypes –
subtypes C, D and SIVcpz reference strains (CPZ.US_MARILYN and
CPZ.SIVcpzCAM13) were included as outgroup. The newly emerged
unique recombinant clusters identified in this study were highlighted as
CRF candidate 1 (10MYKJ036, 11MY1RJ704, 11MY1ZK731 and
11MY1EP794), CRF candidate 2 (10MYKJ067, 10MYKJ079 and
04MYKL016) and CRF candidate 3 (10MYKJ016, 10MYKJ052,
11MY1YC672 and 11MY1JJ741). Bootstrap values of greater than 70%
were indicated on the branch nodes. The scale bar represents 2%
genetic distance (0.02 substitutions per site).
doi:10.1371/journal.pone.0062560.g001
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risks was performed using PAUP* v4.0 beta [40]. Using the
comprehensive alignment comprising of 242 1 kb pol gene
sequences of CRF33_01B genome (HXB2:2253–3260), the past
population dynamics of CRF33_01B was estimated using the
coalescent-based Bayesian Markov chain Monte Carlo (MCMC)
sampling method performed in BEAST v1.7 [41]. An uncorrelat-
ed lognormal relaxed molecular clock [42] was used for the
Bayesian skyline reconstructions. The evolutionary rates and tree
topologies were analysed using the general time-reversible (GTR)
[43] nucleotide substitution parameter with gamma distributed
among-site rate variation with four rate categories (c4) [44]. Each
MCMC chain was run for 30 million states with a sampling rate of
every 10,000 states. The MCMC output was checked for
convergence and effective sampling size using Tracer v1.4
(available at http://tree.bio.ed.ac.uk) with 10% of each chain
discarded as burn-in.
Results
Spread of HIV-1 CRF33_01B and Emergence of Multiple
Recombinant Clusters among PWIDs in Kuala Lumpur,
Malaysia
The recent HIV-1 genotype distribution among PWIDs was
assessed among consented subjects recruited from a prison and a
needle syringe exchange program in Kuala Lumpur, Malaysia. The
HIV-infected adult subjects included 138 males with an age range of
23–56 years old (mean: 36.569.6 years old) and 20 females with an
age range of 24–45 years old (mean: 35.566.8 years old) with a
mean CD4+ T cell count of 438 cells/ml. Among 116 subjects with
available serological data, approximately 93% were anti-HCV
positive. The majority (89.8%) of subjects were antiretroviral
(ARV)-naive at the time of sample collection. HIV-1 genotype
assignment was determined by population sequencing and phylo-
genetic analysis of the gag-pol gene spanning the gag-PR and RT
regions. From 158 HIV-positive PWIDs, the gag-pol genes were
successfully amplified in 81% (128/158) of the study subjects in
which a 1683 bp gag-pol contig (HXB2:1753–3440) was assembled
in 77% (98/128) while partial gag-PR (HXB2:1753–2591, 834 bp)
or RT (HXB2:2476–3440, 966 bp) genes were sequenced in 13%
(16/128) and 11% (14/128), respectively of the population.
Based on neighbour-joining phylogenetic reconstructions of the
gag-pol genes (Figure 1) and other partial gag-PR and RT genes
(Figure S1a and S1b), 71% (91/128) of PWIDs isolates were
grouped with the HIV-1 CRF33_01B reference sequences from
the database, indicating a high prevalence of CRF33_01B
circulating in the study population. HIV-1 CRF01_AE/B
recombinants were detected at 13% (16/128) (described in detail
below). This is followed by a lower prevalence rate of other
established HIV-1 genotypes circulating in the region – subtype B9
and CRF01_AE attributing to 11% (14/128) and 5% (7/128),
respectively of the HIV-1 infections among PWIDs. Unlike HIV-1
subtype B9 of Thai origin, western lineages of subtype B were not
identified among the PWIDs in this study. Likewise, other
previously described CRFs in Southeast Asia such as CRF15_01B,
CRF34_01B, CRF48_01B, CRF51_01B and CRF52_01B were
also not detected in the study population.
Of note, four isolates (10MYKJ036, 11MY1RJ704,
11MY1ZK731 and 11MY1EP794) showed unique tree topology
by grouping together with a previously reported CRF01_AE/B
recombinant (06MYKLD46) [45] at the base of the CRF33_01B
clade, supported by a bootstrap value of 71% in the neighbour-
joining tree (Figure 1). The four isolates sequenced in this study
seemed to have diverged from 06MYKLD46 lineage and formed a
well-supported clade (98% bootstrap value). Nucleotide sequences of
these five isolates were submitted to the RIP tool at the HIV database
and later bootscanned (using HIV-1 CRF01_CM240 and B9_RL42
as the putative parental genotypes) by SimPlot, showing evidence of
identical CRF01_AE/B mosaic genome structure shared among the
four isolates except 06MYKLD46 (Figure 2B and Figure S2).
Informative sites analyses revealed the recombination of two subtype
B9 segments at HXB2 positions 2064–2665 and 3260–3440 nt
shared by all four isolates (10MYKJ036, 11MY1RJ704,
11MY1ZK731 and 11MY1EP794) in addition to the CRF01_AE
segments at positions 1753–2052 and 2690–3194 nt. In all four
isolates, similar multiple recombination breakpoints were identified at
positions 2053–2063, 2666–2689 and 3195–3259 nt.
Furthermore at the base of subtype B or B9 clade, an isolate
11MY1MR851 formed a clade with a previously reported
CRF01_AE/B recombinant (07MYKLD49) [46] and supported
by 99% bootstrap value (Figure 1). Further analysis was
performed to determine their putative recombination structures
(Figure 2C) where it was revealed that both isolates shared similar
recombination breakpoints with a subtype B9 fragment at position
1753–3164 nt and followed by a CRF01_AE segment at position
3218–3440 nt. On the other hand, there were four isolates that
were not grouped with any known reference subtypes, CRFs or
URF, namely 10MYKJ086, 11MY2NF831, 11MY3HA741 and
11MY1IM781 (Figure 1). Isolate 10MYKJ086 was located
outside the CRF33_01B clade, displaying a mosaic genome
pattern with subtype B9 and CRF01_AE segments at positions
1753–2840 and 2876–3440 nt, respectively (Figure 2C). Second-
ly, an isolate located at the base of CRF48_01B clade,
11MY2NF831 displayed a subtype B9 segment at position 2173–
2665 nt and two CRF01_AE segments at positions 1753–2110 nt
and 2735–3440 nt. Thirdly, isolate 11MY3HA741 located outside
the CRF01_AE clade showed a subtype B9 segment at position
2168–2225 nt and two CRF01_AE segments at positions 1753–
2135 and 2291–3440 nt. Finally, a more complex recombination
structure was observed in isolate 11MY1IM781 whereby two
subtype B9 segments were identified at positions 2426–2810 and
3161–3440 nt with CRF01_AE segments at positions 1753–2309
and 2876–3147 nt.
Figure 2. Bootscan analyses of HIV-1 unique recombinant forms (URFs) isolated from people who inject drugs (PWID) in Malaysia.
A, Schematic representation of the full length recombinant structure of CRF33_01B with the four unique recombination breakpoints labelled as 1–4
(HXB2:2053–2063 nt, 2375–2416 nt, 2538–2540 nt and 2841–2875 nt, respectively) in the gag-pol region [21]. B, Bootscanning plots of three novel
CRF candidates (1 to 3) generated from the 1.6 kb gag-pol gene (HXB2:1753–3440 nt) using SimPlot version 3.5.1 [36]. HIV-1 reference strains
CRF01_CM240 (CRF01_AE) and B9_RL42 (Thai subtype B9) were selected as the putative parental genotypes by similarity plotting and C_95IN21068
(subtype C) as an outgroup, with a window size of 200 nucleotides moving along the alignment in increments of 50 nucleotides to define the
recombination structures. The shared recombination breakpoints between the URFs were highlighted and in cases where the breakpoints were also
shared with CRF33_01B, these breakpoints were further numbered (1 to 4). Each sub-region of these CRF candidates was also indicated and described
further in Figure 3. C, Bootscanning plots of unique recombinant forms (URFs) –11MY1MR851 (sharing a similar recombination breakpoint with
07MYKLD49 [46]), 10MYKJ086, 11MY2NF831, 11MY3HA741 and 11MY1IM781 displaying distinct recombinant structures in the 1.6 kb gag-pol
sequences amplified among the PWIDs study population. For clarity, bootscanning plots of partial RT and gag-PR sequences (11MY1JJ741 and
10MYKJ084, respectively) were not displayed here but their recombination structures have been discussed in detail in the text.
doi:10.1371/journal.pone.0062560.g002
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Given the significant presence of HIV-1 CRF01_AE/B
recombinants detected in the gag-pol genes, we proceeded to
screen every newly generated sequence data using a suite of
recombination analysis tools (RIP, bootscan and informative sites
analyses mentioned above) to identify the presence of other URFs
that may not be readily identified based on the tree topology.
Interestingly, based on the 1.6kb gag-pol genes, we identified two
other unique lineages within the CRF33_01B clade that showed
distinct genomic structures compared to that of CRF33_01B
(Figure 1). A group of sequences consisting of isolates
10MYKJ067, 10MYKJ079 and a previously reported URF,
04MYKL016 [21] showed a short subtype B9 segment (311bp)
identified at position 2064–2374 nt in relation to the unique
recombination breakpoints at positions 2053–2063 and 2375–
2422 nt shared by all three isolates. Meanwhile CRF01_AE
segments were identified at positions 1753–2052 and 2423–
3440 nt in these isolates. The origin of each segment was
confirmed by sub-region tree analyses using a selected panel of
CRF01_AE and B9 parental strains (Figure 3). It is important to
note that the recombination pattern for these isolates was related
to that of CRF33_01B, although the subtype B9 segment in
CRF33_01B (at position 2541–2840 nt) [21] was not present
among these novel recombinants (Figure 2A and 2B). In the
other lineage, three isolates (10MYKJ016, 10MYKJ052 and
11MY1YC672) clustered with 87% bootstrap support also shared
similar unique recombination breakpoints upon detailed recom-
bination analyses. In these three isolates, three subtype B9
segments were identified at positions 2064–2374, 2552–2840
and 3161–3283 nt whereas four segments at positions 1753–2052,
2417–2537, 2876–3147 and 3326–3440 nt were identified as
CRF01_AE (Figure 2B). Moreover, analysis of partial RT
(HXB2:2476–3440) sequences also revealed an additional isolate
(11MY1JJ741) closely related to the isolates 10MYKJ016,
10MYKJ052 and 11MY1YC672 (supported by an 86% bootstrap
value) and shared similar recombinant structures in the RT region
as described (Figure S1a and Figure 2B). Likewise, analysis of
the partial gag-PR sequences had identified an isolate within the
CRF33_01B clade harbouring unique recombinant structures
distinct from any other isolates. For example, partial gag-PR
sequence of isolate 10MYKJ084 displayed a subtype B9 segment at
position 2168–2374 nt and CRF01_AE segments at positions
1753–2135 and 2417–2591 nt.
Altogether, the present study identified a high prevalence of
novel CRF01_AE/B recombinants displaying unique recombina-
tion structures in 13% (16/128) of PWIDs study population. This
finding indicated the increasing genetic diversity of HIV-1 with a
higher prevalence of recombinants (CRF33_01B and novel
CRF01_AE/B recombinants) comprising a total of 84% of the
HIV-1 infections among PWIDs.
History and Transmission Pattern of HIV-1 CRF33_01B in
Malaysia
HIV-1 CRF33_01B was first characterized in 2003 among
various high-risk populations in Malaysia [17,21]. The present
study, deemed to be the first large-scale molecular epidemiological
surveillance conducted among HIV-1 infected PWIDs in Kuala
Lumpur, Malaysia, revealed a significantly high prevalence of
CRF33_01B (71%) in this population, warranting an in-depth
investigation into the history and transmission pattern of
CRF33_01B extending to various risk groups in the country.
Using a comprehensive data set of 242 CRF33_01B sequences (pol
region, HXB2:2253–3260) spanning year 2005–2012 among
individuals from various risk groups (inclusive of 152 and 90
sequences with known and unknown transmission risks, respec-
tively) and geographical origins (central, northern and eastern
states of Malaysia), the past population dynamics of CRF33_01B
was estimated by incorporating high-resolution analyses of
maximum likelihood [40] and Bayesian sampling approach [47].
The data set of CRF33_01Bpol sequences were amplified from
HIV-1 positive samples collected from the following regions: the
central states of Malaysia (n = 142) including Kuala Lumpur
(n= 54, including four CRF33_01B reference sequences [21]),
Selangor (n = 86) and Negeri Sembilan (n = 2); the northern states
(n = 85) including Kelantan (n= 79) and Perak (n = 6); and the
eastern state (n = 13) of Pahang [22]. Indonesian CRF33_01B
reference sequences (n = 2) were also retrieved from the online
database [27] and included in the analyses.
Genealogy-based maximum likelihood analysis of CRF33_01Bpol
data set containing 152 sequences with known transmission risks
revealed a phylogenetic tree with star-like appearance in which the
terminal tree branches (mean length: 0.02560.014) were in general
longer than the internal branches (mean length: 0.00560.005)
(Figure 4A). A number of CRF33_01B sub-lineages were observed,
with isolates from the PWIDs predominantly sampled from the
central states located at the base of these lineages showing apparent
founder effect. Of note, internal nodes of CRF33_01B sequences
from pediatric subjects who acquired infection from their mothers
were positioned near the terminal or the tip of the tree. Next, in
order to investigate the demographic history of CRF33_01B
infections in Malaysia, specifically the past population dynamics,
we estimated the effective population sizes of CRF33_01B through
time by generating a Bayesian skyline plot using a total of 242
CRF33_01Bpol data set (inclusive of 90 sequences with unknown
transmission risks) (Figure 4B). From the plot, it was observed that
the effective population size of CRF33_01B had remained
significantly high since early 2000s for almost a decade, suggesting
that the virus had established itself among various risk groups in the
HIV-infected population along with other main circulating
genotypes - CRF01_AE and subtype B9 in Malaysia. The plot
Figure 3. Sub-region trees analyses of the unique recombinant clusters. The gag-pol genes were sequenced, codon-aligned and manually
adjusted with the HIV-1 reference subtypes and circulating recombinant forms (CRFs) retrieved from the Los Alamos HIV database (http://www.hiv.
lanl.gov/). The 1.6kb gag-pol sequences of the unique recombinant clusters were subdivided into regions (denoted by Roman letters) in relation to
the unique recombination breakpoints estimated by informative site analysis. Sub-region neighbour-joining trees were constructed in MEGA 5.05 [34]
using Kimura 2-parameter method for nucleotide substitutions to estimate pair-wise evolutionary distance. The reliability of the branch nodes were
assessed by bootstrap analysis of 1000 replicates. Bootscan plots and sub-region neighbour-joining trees for each CRF candidates were shown: A,
novel CRF candidate 1 (10MYKJ036, 11MY1RJ704, 11MY1ZK731 and 11MY1EP794), B, novel CRF candidate 2 (10MYKJ067, 10MYKJ079 and
04MYKL016) and C, novel CRF candidate 3 (10MYKJ016, 10MYKJ052, 11MYIYC672 and 11MY1JJ741). HIV-1 reference strains CRF01_CM240
(CRF01_AE) and B9_RL42 (Thai subtype B9) were selected as the putative parental genotypes by similarity plotting and included in the bootscan plots
(from Figure 2). The novel CRF candidate 1 or CRF33_01B were highlighted where the sequences formed a clade in the respective sub-region trees.
In cases where the sub-region of CRF33_01B clustered with the reference strains of either putative parental genotypes - CRF01_AE or B9 showing the
parental origin, the parental genotype was highlighted. The HXB2 nucleotide positions and sequence length of individual sub-regions were indicated
in the illustration. Bootstrap values of greater than 70% were indicated on the branch nodes. The scale bar for respective sub-region trees was also
indicated (in substitutions per site).
doi:10.1371/journal.pone.0062560.g003
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correlated well with our current epidemiological finding reported in
this study where CRF33_01B was massively expanding in the
PWIDs study population.
Discussion
People who inject drugs comprise 70% of the total HIV-1
infection cases reported in Malaysia from 1986–2011. Among an
estimated 170,000 PWIDs in Malaysia by the end of 2011,
approximately 65,032 cases of HIV-1 infections had been reported
in the population and 14% (9,141) suffered AIDS-related deaths
[5]. Previous molecular epidemiological studies indicated a high
prevalence of HIV-1 CRF33_01B among PWIDs compared to
other risk groups involving heterosexuals and homo2/bi-sexual
males [21]. Similar investigation conducted among PWIDs in a
remote fishing community from the eastern state of Malaysia
reported similar findings [22]. However these studies were often
limited in sampling size which hindered an in-depth HIV-1
molecular surveillance among PWIDs to be conducted in the
country. In the present study, a large-scale molecular epidemio-
logical surveillance and phylodynamic analysis of HIV-1 were
conducted among 158 consented PWIDs recruited between 2010
and 2011 in Kuala Lumpur, Malaysia based on population
sequencing and phylogenetic reconstructions of the HIV-1 gag-pol
gene. We had for the first time provided robust genetic evidence
highlighting the massive spread of HIV-1 CRF33_01B among the
PWIDs, its epidemiological influence in other low-risk populations,
and the evolutionary history of CRF33_01B prior to establishing
its endemicity in the country.
In this study, approximately 71% of the recruited PWIDs
population were found to be infected with HIV-1 CRF33_01B.
The finding suggested that a profound epidemiological shift had
occurred in the recent years following the first description of
Figure 4. Maximum likelihood analysis and past population dynamics of HIV-1 CRF33_01B disseminating among various risk
groups in Southeast Asia (Malaysia and Indonesia). The maximum likelihood reconstruction and past population dynamics of all available
CRF33_01B isolates was estimated by PAUP* v4.0 beta [40] and the Bayesian sampling approach implemented in BEAST v1.7 [47], respectively. A total
of 242 CRF33_01B sequences (pol region, HXB2:2253–3260) spanning year 2005–2012 among individuals from various risk groups (inclusive of 152
and 90 sequences with known and unknown transmission risks, respectively) and geographical origins (central, northern and eastern states of
Malaysia) and two full-length sequences from Indonesia were analyzed. The data set of CRF33_01Bpol sequences were amplified from HIV-1 positive
samples collected from the following regions: the central states of Malaysia (n = 142) including Kuala Lumpur (n = 54, including four CRF33_01B
reference sequences [21], Selangor (n = 86) and Negeri Sembilan (n = 2); the northern states (n = 85) including Kelantan (n = 79) and Perak (n = 6); and
the eastern state (n = 13) of Pahang [22]. Indonesian CRF33_01B reference sequences (n = 2) were retrieved from the online database [27] and
included in the analyses. A, Maximum likelihood analysis of CRF33_01Bpol data set containing 152 sequences with known transmission risks revealed
a phylogenetic tree with star-like appearance, in which the terminal tree branches (mean length: 0.02560.014) were in general longer than the
internal branches (mean length: 0.00560.005), possibly suggesting a high growth rate for CRF33_01B during the early phase of the epidemic [48]. In
addition, tree topology showed the dissemination of HIV-1 CRF33_01B from PWIDs to other risk groups including the low-risk populations, notably
among children who acquired infections through their mothers. B, The Bayesian skyline plot estimated the past population dynamics of CRF33_01B
among various risk groups in Malaysia using the CRF33_01Bpol data set of 242 sequences mentioned above (and also in the text). The x-axis
represents the time (in units of year) and y-axis represents the effective population size of CRF33_01B. The thick solid line in the plot represents the
median estimate and the shaded region represents the 95% highest posterior density (HPD) credible region. The Bayesian skyline plot revealed an
exponential increase in effective number of CRF33_01B infections in the host population since its reported emergence around 1991 to 1993 [31] until
early 2000s and remained stable thereafter at a high prevalence, suggesting persistent viral transmission and endemicity of CRF33_01B among
various risk groups in Malaysia.
doi:10.1371/journal.pone.0062560.g004
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CRF33_01B almost a decade ago [17,21]. Previously established
HIV-1 genotypes – subtype B9 and CRF01_AE which played an
important role during the early HIV-1 epidemic among PWIDs
and heterosexuals, respectively in Southeast Asia including
Malaysia [6,9,13–15] were reported at a substantially lower
frequency with a combined prevalence of less than one-fifth of the
total study population. Globally, 86% of HIV-1 infections in South
and Southeast Asia (excluding India) is attributed to CRF01_AE
while HIV-1 recombinants (including CRFs and URFs) comprised
20% of the infections worldwide [12]. Interestingly, CRF33_01B
and multiple novel CRF01_AE/B9 unique recombinants identified
in this study comprised an alarming 84% of total HIV-1 infections
among PWIDs. The remarkably high prevalence of CRF33_01B
and CRF01_AE/B9 recombinants described implied the escalating
genetic diversity and complexity of HIV-1 in Malaysia compared
to almost two decades ago when CRF01_AE and subtype B9 were
the two major circulating strains reported among this population
[13–15]. On the other hand, the western lineage of subtype B and
other CRFs previously described in neighbouring countries
(CRF15_01B and CRF34_01B from Thailand, CRF51_01B from
Singapore and CRF52_01B from both Malaysia and Singapore)
were not identified in the present study, suggesting the importation
of foreign HIV-1 lineages into the injecting drug population in
Malaysia was uncommon or a possible extinction of these
imported lineages within the enclosed injecting drug networks in
Malaysia. Viral population dynamics was estimated to illustrate
the past changes in effective population size of CRF33_01B, which
reportedly emerged between 1991 and 1993 [31]. Mapping back
to almost two decades, the Bayesian skyline plot revealed an
exponential increase in the effective number of CRF33_01B
infections in the host population since its emergence until early
2000 s and remained stable thereafter at a high prevalence,
suggesting persistent viral transmission and endemicity of
CRF33_01B among various risk groups in Malaysia (Figure 4B).
The star-like tree structure generated by maximum likelihood
analysis, as indicated by terminal branches that were generally
longer than the internal branches, was in concordance with the
high growth rate of CRF33_01B during the early phase of the
epidemic [48] (Figure 4A). Spatial analysis based on phylogenetic
reconstruction showed vague evidence of directional gene flow
from the central to other northern and eastern states, although a
high proportion of early transmission events can be traced to
PWIDs recruited from the central region (Figure S3). Further-
more, the dissemination of HIV-1 CRF33_01B from PWIDs to
other risk groups including low-risk populations, most notably
among children (mean age: 4.2 months) who acquired infections
through their mothers via mother-to-child transmission, was also
observed (Figure 4A). Together with CRF33_01B sequences
isolated from pediatric subjects mainly recruited from the northern
states [49], coalescent-based analysis showed considerable place-
ment of the internal nodes for pediatric CRF33_01B lineages
around the terminal positions of the tree, indicating a relatively
recent divergence times. To our knowledge, the finding suggested
for the first time the increasing transmission of HIV-1
CRF33_01B from PWIDs to the general population in the
country. It is therefore not unexpected if more distinct inter-
subtype recombinants involving CRF01_AE, subtype B9 and the
recent highly prevalent CRF33_01B genotypes emerge encom-
passing various high and low risk populations infected with HIV-1,
further increasing the genomic diversity of the complex HIV-1
molecular epidemiology in the general population.
In effect, multiple novel unique recombinants were identified in
this study among 13% of PWIDs by analysing the 1.6 kb gag-pol
and partial PR/RT sequences using an extensive array of
recombination analysis tools (RIP, SimPlot, bootscan and infor-
mative sites), in which ten unique recombinants characterised from
seemingly non-epidemiologically linked individuals shared one or
more recombination breakpoints with CRF33_01B (CRF33_01B
comprised of two subtype B9 fragments recombined with
CRF01_AE in the gag-pol region [21]). For example, the novel
CRF candidate 1 (10MYKJ036, 11MY1RJ704, 11MY1ZK731
and 11MY1EP794) shared one identical breakpoint with
CRF33_01B in the gag region (Figure 2A, 2B). Novel CRF
candidate 2 (10MYKJ067, 10MYKJ079 and 04MYKL016)
shared the first subtype B9 fragment with CRF33_01B and CRF
candidate 3 (10MYKJ016, 10MYKJ052, 11MY1YC672 and
11MY1JJ741) shared both subtype B9 fragments with CRF33_01B
with an additional fragment of subtype B9 recombined in the pol
region. It is important to note that the incorporation of RIP
analysis in this study proved to be invaluable in rapidly identifying
unique recombinants forms/clades which were otherwise indistin-
guishable based on the neighbour-joining tree topology, for
example in the case of both novel CRF candidates 2 and 3 which
were grouped discreetly within the CRF33_01B clade. The high
degree of genetic relatedness among the three distinct CRF
candidates with CRF33_01B was favourably suggestive of on-
going inter-subtype recombination involving CRF33_01B and the
co-circulating CRF01_AE and subtype B9 in the country, that may
be facilitated by the broad distribution of CRF33_01B among
drug injecting networks. Full length genome sequencing of these
clades are currently underway to ascertain the complete recom-
binant profiles for CRF assignment [50] followed by phylogenetic
inference to discern the possible ancestral relationships among
these recombinogenic lineages.
In summary, we describe the first genomic and epidemiological
data demonstrating the massive expansion of HIV-1 CRF33_01B
among the high-risk injecting drug use population and its
subsequent spread into the general population in Malaysia. The
discovery of multiple unique recombinant clusters closely related
to CRF33_01B also indicated the emergence of a group of novel
second-generation CRFs in Southeast Asia. As a result of the
dynamics and extreme genetic variance of HIV-1 in the region,
continual effort in designing effective treatment and prevention
strategies must be improved.
Supporting Information
Figure S1 Phylogenetic analysis of the partial gag-PR
(HXB2:1753–2591) and partial RT (HXB2:2476–3440)
HIV-1 sequences amplified among people who inject
drugs (PWID) in Kuala Lumpur, Malaysia. The partial gag-
PR (n= 16) and partial RT (n= 14) genes were sequenced, codon-
aligned and manually adjusted with the HIV-1 reference subtypes
and circulating recombinant forms (CRFs) retrieved from the Los
Alamos HIV database (http://www.hiv.lanl.gov/). Neighbour-
joining tree was constructed in MEGA 5.05 [34] using Kimura 2-
parameter method of nucleotide substitutions to estimate pair-wise
evolutionary distance and the reliability of the branching nodes
were assessed by bootstrap analysis of 1000 replicates. Reference
strains of established and informative HIV-1 genotypes –
CRF01_AE, subtype B (including Thai B9), CRF15_01B,
CRF34_01B CRF33_01B, CRF48_01B, CRF51_01B,
CRF52_01B and other relevant unique recombinant forms (URFs)
circulating in Southeast Asia were also included in the analysis to
improve tree resolution. Other HIV-1 genotypes – subtypes C, D
and SIVcpz reference strains (CPZ.US_MARILYN and
CPZ.SIVcpzCAM13) were included as outgroup. The newly
emerged unique recombinant clusters identified in this study were
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highlighted in Figure S1b as CRF candidate 1 (10MYKJ036,
11MY1RJ704, 11MY1ZK731 and 11MY1EP794), CRF candi-
date 2 (10MYKJ067, 10MYKJ079 and 04MYKL016) and CRF
candidate 3 (10MYKJ016, 10MYKJ052, 11MY1YC672 and
11MY1JJ741). Bootstrap values of greater than 70% were
indicated on the branch nodes. The scale bar represents 5% and
2% genetic distances (in substitutions per site), respectively.
(PDF)
Figure S2 Bootscan analyses of HIV-1 unique recombi-
nant forms (URFs) constituting three novel clades of
circulating recombinant forms (CRFs) isolated from
people who inject drugs (PWID) in Malaysia. A, Schematic
representation of the full length recombinant structure of
CRF33_01B with the four unique recombination breakpoints
labelled as 1–4 (HXB2:2053–2063 nt, 2375–2416 nt, 2538–
2540 nt and 2841–2875 nt, respectively) in the gag-pol region
[21]. B, Bootscanning plots of three novel CRF candidates (1 to 3)
and a previously published URF, 06MYKLD46 [45] generated
from the 1.6 kb gag-pol gene (HXB2:1753–3440 nt) using SimPlot
version 3.5.1 [36]. HIV-1 reference strains CRF01_CM240
(CRF01_AE) and B9_RL42 (Thai subtype B9) were selected as
the putative parental genotypes by similarity plotting and
C_95IN21068 (subtype C) as an outgroup, with a window size
of 200 nucleotides moving along the alignment in increments of 50
nucleotides to define the recombination structures. The shared
recombination breakpoints between the URFs were highlighted
and in cases where the breakpoints were also shared with
CRF33_01B, these breakpoints were further numbered (1 to 4).
In comparison with other four isolates of novel CRF candidate 1,
06MYKLD46 displayed distinct recombination structures and
breakpoints in the gag-pol genes (as indicated by arrows) and is thus
excluded as a possible candidate.
(EPS)
Figure S3 Maximum likelihood analysis of HIV-1
CRF33_01B disseminating among various risk groups
and geographical origins in Southeast Asia (Malaysia
and Indonesia). The maximum likelihood reconstruction of all
available CRF33_01B isolates was estimated by PAUP* v4.0 beta
[40]. A total of 242 CRF33_01B sequences (pol region,
HXB2:2253–3260) spanning year 2005–2012 among individuals
from various risk groups (inclusive of 152 and 90 sequences with
known and unknown transmission risks, respectively) and
geographical origins (central, northern and eastern states of
Malaysia) and two full-length sequences from Indonesia were
analyzed. The data set of CRF33_01Bpol sequences were amplified
from HIV-1 positive samples collected from the following regions:
the central states of Malaysia (n = 142) including Kuala Lumpur
(n= 54, including four CRF33_01B reference sequences [21],
Selangor (n = 86) and Negeri Sembilan (n = 2); the northern states
(n = 85) including Kelantan (n= 79) and Perak (n = 6); and the
eastern state (n = 13) of Pahang [22]. Indonesian CRF33_01B
reference sequences (n = 2) were retrieved from the online
database [27] and included in the analyses. Spatial analysis based
on phylogenetic reconstruction of CRF33_01Bpol data set
comprising 242 sequences from various geographical origins
revealed vague evidence of directional gene flow from the central
to other northern and eastern states, although a high proportion of
early transmission events can be traced to PWIDs recruited from
the central region.
(EPS)
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